Safety and efficacy of phage therapy in difficult-to-treat infections: studies in Chinese literature

Affiliations

¹ Center of Infectious Diseases, West China Hospital (Huaxi), Sichuan University, Guoxuexiang 37, Chengdu, 610041, China.
² Center of Infectious Diseases, West China Hospital (Huaxi), Sichuan University, Guoxuexiang 37, Chengdu, 610041, China. zongzhiy@scu.edu.cn.

Comment

Xin Yin et al. Eur J Clin Microbiol Infect Dis. 2022 Oct.

. 2022 Oct;41(10):1279-1281.

doi: 10.1007/s10096-022-04490-9. Epub 2022 Sep 6.

¹ Center of Infectious Diseases, West China Hospital (Huaxi), Sichuan University, Guoxuexiang 37, Chengdu, 610041, China.
² Center of Infectious Diseases, West China Hospital (Huaxi), Sichuan University, Guoxuexiang 37, Chengdu, 610041, China. zongzhiy@scu.edu.cn.

No abstract available

Comment on

Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review.
Uyttebroek S, Chen B, Onsea J, Ruythooren F, Debaveye Y, Devolder D, Spriet I, Depypere M, Wagemans J, Lavigne R, Pirnay JP, Merabishvili M, De Munter P, Peetermans WE, Dupont L, Van Gerven L, Metsemakers WJ. Uyttebroek S, et al. Lancet Infect Dis. 2022 Aug;22(8):e208-e220. doi: 10.1016/S1473-3099(21)00612-5. Epub 2022 Mar 3. Lancet Infect Dis. 2022. PMID: 35248167

1. Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, Ouellette M, Outterson K, Patel J, Cavaleri M, Cox EM, Houchens CR, Grayson ML, Hansen P, Singh N, Theuretzbacher U, Magrini N, Group WHOPPLW (2018) Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 18:318-327
1. Uyttebroek S, Chen B, Onsea J, Ruythooren F, Debaveye Y, Devolder D, Spriet I, Depypere M, Wagemans J, Lavigne R, Pirnay J-P, Merabishvili M, De Munter P, Peetermans WE, Dupont L, Van Gerven L, Metsemakers W-J (2022) Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review. Lancet Infect Dis 22:e208–e220 - DOI
1. Chen P, Kong Y, Wen S, Gu X, Zhou Y, Tan X, Ma Y, Lu H (2022) A case report of phage therapy against lung infection caused by carbapenem-resistant Acinetobacter baumannii and carbapenem-resistant Pseudomonas aeruginosa. Electron J Emerging Infect Dis 7:71–75
1. Li L, Li J, Bin H, Wu N, Zhu T, Guo X, Chen Z (2021) Clinical application and effect of phage on the treatment of pulmonary infection by pan-drug resistant Klebsiella pneumoniae. J Shanghai Jiaotong Univ (Med Sci) 41:1272
1. Zeng Y, Bao J, Tan D, Zhang Y, Guo M, Zhu Z, Shao E, Zhu T (2020) Application of phage in patients with urinary tract pandrug-resistant Klebsiella pneumoniae infection. Chin J Urol 41:677–680